Table 1 Characteristics of the investigated patients groups
From: Phase dependent hypothalamic activation following trigeminal input in cluster headache
| Â | Age | Sex | Years of cluster headache | Number of patients taking prophylactic medication | Medication taken |
|---|---|---|---|---|---|
Active Cluster Headache | 50,0833333 | 12 m, 4 f | 13,203,125 | 9 | Verapamil (2), Verapamil+Topiramate (1), Lithium (2), Prednisolon (1), Allegro (1), Verapamil+Allegro (1), Almotriptan (1) |
Inactive Cluster Headache | 45,2,380,952 | 18 m, 3 f | 14,55 | 6 | Verapamil (3),Topiramate (1), Verapamil + Topiramate (2) |